Fig. 2From: Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCIEffect of the study drugs on adaptive tracker. The shaded area represents the 95% CI. The estimated difference in mean change from baseline between methylphenidate and placebo was significant (p = 0.002)Back to article page